MariMed: 213% YoY Increase In Q3, Adjusted EBITDA, Reaffirms Full-Year Revenue Guidance Of $118M

Multi-state operator MariMed, Inc. (OTCQX: MRMD) reported its financial and operating results Monday for the quarter ended September 30.
Q3 Financial Highlights
• Revenue totaled $33.2 million, representing an increase of 147% from the third quarter of 2020.
• Gross profit was $18.2 million, an increase of 109% from the third quarter of 2020.
• Adjusted EBITDA, s non-GAAP measure, of $12.9 million, a 213% increase from the third quarter of 2020.
• Net income of $2.1 million, a 25% increase from the third quarter of 2020.
• Working capital at the end of the quarter of $27.3 million compared to a working capital deficit of $2.2 million at the end of 2020.
• $10.7 million of cash flow from operations for the quarter and a total of $28.2 million …

Full story available on Benzinga.com

More MariMed: 213% YoY Increase In Q3, Adjusted EBITDA, Reaffirms Full-Year Revenue Guidance Of $118M